{"id":10980,"date":"2024-12-20T10:03:01","date_gmt":"2024-12-20T17:03:01","guid":{"rendered":"https:\/\/www.prfire.com\/news-releases\/worlds-first-3d-printed-personalized-breast-tissue-regenerative-implants-successfully-used-in-real-clinical-practice\/"},"modified":"2024-12-20T10:03:01","modified_gmt":"2024-12-20T17:03:01","slug":"worlds-first-3d-printed-personalized-breast-tissue-regenerative-implants-successfully-used-in-real-clinical-practice","status":"publish","type":"news-releases","link":"https:\/\/www.prfire.com\/news-releases\/worlds-first-3d-printed-personalized-breast-tissue-regenerative-implants-successfully-used-in-real-clinical-practice\/","title":{"rendered":"World’s First 3D-Printed Personalized Breast Tissue Regenerative Implants Successfully Used In Real Clinical Practice"},"content":{"rendered":"
\n
\nCAIRO, EGYPT. December 20th, 2024<\/strong> – Dr. Mohamed Lofty Hamed has achieved a groundbreaking milestone in the field of cosmetic surgery, performing the world\u2019s first real-world clinical case of breast augmentation using 3D-printed, personalized implants. Unlike previous and current efforts, which were confined to experimental settings or regulatory approval trials, this innovation marks a transformative moment in practical, patient-centered care.<\/p>\n

Recently published in Plastic and Reconstructive Surgery Global Open<\/a> – the official open-access journal of the American Society of Plastic Surgeons (ASPS)\u2014 the study details a revolutionary approach to breast augmentation that combines cutting-edge science with patient-specific artistry. Also it highlights Dr. Hamed\u2019s unique dual role as both scientist and surgeon. From conceptualizing the technology to its clinical implementation he served as both the innovator scientist and the performing surgeon, developed and implemented custom implants designed to seamlessly integrate with the body.<\/p>\n

\u201cThese implants are not just a technological advancement\u2014they are a step toward redefining what\u2019s possible in future plastic surgery,\u201d said Dr. Hamed. \u201cBringing this innovation from the lab to the operating room required not only scientific ingenuity but also surgical precision, and I am honored to have played both roles in this breakthrough.\u201d<\/p>\n

Crafted from ultra-lightweight, biocompatible materials, the implants weigh just 33 grams\u2014significantly lighter than traditional silicone implants, which can weigh over 10 times as much. This unique design reduces stress on the body while promoting natural tissue regeneration and vascularization. The implants were custom-designed using advanced technologies such as artificial intelligence, 3D printing, and plasma surface treatment to create a structure.<\/p>\n

Using state-of-the-art technologies, including artificial intelligence, 3D printing, and plasma surface treatments, Dr. Hamed innovated implants that mimics the natural properties of breast tissue with tissue regeneration capabilities and tailored to the anatomy and preferences of a 28-year-old yoga instructor. The patient sought a safer, more natural alternative to traditional implants and expressed concerns about their compatibility with her active lifestyle. Eight months post-surgery, the results demonstrated no complications, seamless tissue integration, and a highly satisfactory aesthetic outcome.\u00a0<\/p>\n

\u201cThis isn\u2019t just a new type of implant\u2014it\u2019s a new horizon of plastic surgery ,\u201d Dr. Hamed explained. \u201cBy eliminating risks like capsule formation and foreign body\u00a0 ensuring the implants work harmoniously with the body not against it, we\u2019ve opened the door to safer, more personalized plastic surgery solutions.\u201d\u00a0<\/p>\n

Dr. Hamed emphasized that while this innovation is a game-changer, further long-term studies are necessary to confirm its widespread applicability. Nevertheless, the successful application in a real clinical setting\u2014not as part of regulatory trials\u2014paves the way for a new era in personalized plastic surgery.\u00a0<\/p>\n

ENDS<\/p><\/div>\n<\/div>\n","protected":false},"author":1,"featured_media":10981,"menu_order":0,"template":"","meta":{"_acf_changed":false,"content-type":"","site-sidebar-layout":"default","site-content-layout":"default","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":""},"news-rooms":[7157],"press-tags":[],"press-categories":[2522],"class_list":["post-10980","news-releases","type-news-releases","status-publish","has-post-thumbnail","hentry","news-rooms-mohamed","press-categories-medical"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-releases\/10980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-releases"}],"about":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/types\/news-releases"}],"author":[{"embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/media\/10981"}],"wp:attachment":[{"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/media?parent=10980"}],"wp:term":[{"taxonomy":"news-rooms","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/news-rooms?post=10980"},{"taxonomy":"press-tags","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/press-tags?post=10980"},{"taxonomy":"press-categories","embeddable":true,"href":"https:\/\/www.prfire.com\/wp-json\/wp\/v2\/press-categories?post=10980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}